Results of a new multicenter study published in the New England Journal of Medicine found that vaccination with a primary series of the Pfizer-BioNTech mRNA COVID-19 vaccine reduced the risk of COVID-19-associated hospitalizations in children ages 5-11 years by two-thirds during the Omicron period.
COVID-19 vaccine protects kids and teens from severe illness
April 19, 2022
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022